Evidence map›Paper›PMID 21282644›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2011

Signatures of murine B-cell development implicate Yy1 as a regulator of the germinal center-specific program.

Michael R Green, Stefano Monti, Riccardo Dalla-Favera, Laura Pasqualucci, Nicole C Walsh, Marc Schmidt-Supprian, Jeffery L Kutok, Scott J Rodig, Donna S Neuberg, Klaus Rajewsky and 4 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Loss of Pax5 Exploits Sca1-BCR-ABLCancer research · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 1 country.

Michael R GreenThe Dana-Farber Cancer Institute, Boston, MA 02115, USA.
Stefano Monti
Riccardo Dalla-Favera
Laura Pasqualucci
Nicole C Walsh
Marc Schmidt-Supprian
Jeffery L Kutok
Scott J Rodig
Donna S Neuberg
Klaus Rajewsky
Todd R Golub
Frederick W Alt
Margaret A Shipp
John P Manis
Harvard University · USBoston Biomedical Research Institute · USColumbia University · USDana-Farber Cancer Institute · USHarvard University Press · USBoston Children's Hospital · USBrigham and Women's Hospital · USBroad Institute · US

Funding

The Role of BCL-6 in Berminal Center FormationP01CA092625 · NCI · DANA-FARBER CANCER INSTITUTE · PI SHIPP, MARGARET A · 2001 to 2011
$32.9M
Howard Hughes Medical InstituteNCI NIH HHS CA92625NCI NIH HHS P01 CA092625
6 · The paper itself

Abstract

We utilized gene expression profiling of a comprehensive panel of purified developmentally defined normal murine B cells to identify unique transcriptional signatures for each subset. To elucidate transcription factor activities that function in a stage-specific fashion, we used gene sets that share transcription factor targets and found that germinal center B cells had a robust enrichment of up-regulated and down-regulated signatures compared with the other B-cell subsets. Notably, we found Yy1 and its targets to be central regulators of the germinal center B (GCB)-specific transcriptional program with binding of Yy1 to select signature genes in GCB cells, and translation of the Yy1 signatures to human GCB cells. We then tested whether our newly generated, stage-specific transcriptional signatures could be used to link murine lymphoma models to stages of normal B-cell development. Although each of the molecularly defined murine lymphoma models conserved certain stage-specific features of normal B-cell development, there was a significant alteration of the normal differentiation signature following malignant transformation. These findings offer important tools and insights for elucidating differences between normal and malignant B cells.

Indexed as

AnimalsB-Lymphocyte SubsetsCell DifferentiationChromatin ImmunoprecipitationFlow CytometryGene Expression ProfilingGene Expression RegulationGerminal CenterHumansLymphomaMiceYY1 Transcription FactorYy1 protein, mouseYY1 Transcription Factor

Identifiers

PMID21282644
PMCPMC3041080
OpenAlexW2028601867

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.